2D11.2

ICD-11 MMS 2026-01

Neuroblastoma of adrenal gland

Description

Neuroblastomas are malignant tumours that form in certain types of the nerve tissue. It most often begins in the adrenal gland. About 1 out of 3 neuroblastomas start in the adrenal glands and about 1 out of 4 begin in sympathetic nerve ganglia in the abdomen. Most of the rest start in sympathetic ganglia near the spine in the chest or neck, or in the pelvis.

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Neuroblastoma of adrenal gland
  • Adrenal neuroblastoma
  • neuroblastoma NOS
Show allHide
  • Neuroblastoma of unspecified site

Exclusions from above levels

  • 2E07 – Malignant neoplasm metastasis in adrenal gland
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
Show allHide
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2D11.0 – Adenocarcinoma of adrenal gland
  • 2D11.1 – Malignant phaeochromocytoma of adrenal gland
  • 2D11.Y – Other specified malignant neoplasms of adrenal gland
  • 2D11.Z – Malignant neoplasms of adrenal gland, unspecified

Foundation entity

Neuroblastoma of adrenal gland – http://id.who.int/icd/entity/591280607

Allowed postcoordination axes

Part of: 2D11: Malignant neoplasms of adrenal gland › 02: Neoplasms